Michael joined Hayfin in 2018 and is a Director in the Healthcare team.

Prior to joining Hayfin, he spent over three years at Athyrium Capital Management, a US healthcare investment firm where he focused on investment opportunities across credit, private equity, royalties, and other structured securities. Before this, Michael spent one year at Frankel Group, a strategy consulting firm serving the life sciences industry. He graduated from The University of Pennsylvania, earning dual degrees as a member of the Vagelos Life Sciences and Management Program. He holds a BS in Economics from The Wharton School and a BA in Biology from The University of Pennsylvania.